Ivabradine 70771-1864-08
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 2, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA213442
Need to source Ivabradine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ivabradine Hydrochloride | 7.5 mg/1 |
Drug Class
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]
Selected Package
70771-1864-08Selected180 TABLET in 1 BOTTLE (70771-1864-8)
Other packages for this product(1)
60 TABLET in 1 BOTTLE (70771-1864-6)